For patients at high risk for fracture due to osteoporosis
FORTEO (teriparatide [rDNA origin] injection) can help reduce your risk of having another fracture*
FORTEO is a prescription medication used in both men and postmenopausal women with osteoporosis who are at high risk for having broken bones, or fractures. FORTEO is used in both men and women with osteoporosis due to use of glucocorticoid medicines, such as prednisone, for several months, who are at high risk for having broken bones, or fractures. FORTEO can be used by people who have had a fracture related to osteoporosis, or who have several risk factors for fracture, or who cannot use other osteoporosis treatments.
*Only proven in postmenopausal women with osteoporosis. All women took calcium and vitamin D daily.
Lower your monthly cost to $4 with the FORTEO co-pay card†
Patients must have commercial insurance coverage for FORTEO. Offer subject to a monthly cap of wholesale acquisition cost plus usual and customary charges and a separate maximum annual benefit of $9,000. This offer is invalid for patients without commercial insurance coverage or those whose prescription claims are eligible to be reimbursed, in whole or in part, by Medicare Part D, Medicaid, TRICARE or any other state or federal program. Offer void where prohibited by law and subject to change or discontinue without notice. Card activation required. Subject to additional terms and conditions, which can be found here. Offer expires 12/31/2019.
Start managing your osteoporosis with FORTEO
Consult your healthcare provider to determine if FORTEO is right for you.
ǂFDA approval in 2002
§Cumulative worldwide exposure through 31 August 2017 across all approved indications.
FORTEO Connect™ is available for free support
Joining FORTEO Connect™ provides access to a team of professionals committed to helping you get off to a good start. FREE support includes:
- FORTEO information and injection training
- Insurance investigation